Innovacell
Latest round
- Series C
Last raised
- Apr 2022
Total raised
- $15M
Investors
- 4
About Innovacell
Established in 2000 and based in Innsbruck, Austria, Innovacell specializes in the treatment of urinary and fecal incontinence by cell therapies. The company's headquarter is located in Japan and has a branch in Innsbruck. The company has about 30 employees. Dr. Ekkehart Steinhuber, the CEO of the company, worked for 25 years in the pharmaceutical division of Sandoz. The company treats urinary and fecal incontinence through regenerative medicine. The medicine includes ICES13, ICES15, and ICES16. ICES13 is used for treating stress urinary incontinence. ICES15 is used for treating urge incontinence and ICES15 is used for treating passive incontinence. The company also provides contract research and development, manufacturing and analysis services for ATMPs cell therapies.
Who invested in Innovacell
4 investors across 2 rounds
See all investors in Innovacell
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Innovacell
Who invested in Innovacell?
Innovacell has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Innovacell raised?
Innovacell has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Innovacell last raise money?
Innovacell's most recent round on record is a Series C, in Apr 2022.
What does Innovacell do?
Established in 2000 and based in Innsbruck, Austria, Innovacell specializes in the treatment of urinary and fecal incontinence by cell therapies.
Where is Innovacell headquartered?
Innovacell is headquartered in Innsbruck, Austria.
Which VCs invest in companies like Innovacell?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Innovacell's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Innovacell? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.